Endometrial cancer: open trials in Taiwan

15 open trials have a site in Taiwan. Registry data; only the trial team decides who can take part.

NCT07578649
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer
Trial Treatment · Phase 3 · Pfizer
Taichung Veterans General Hospital, Taichung · China Medical University Hospital, Taichung
Registry updated 2026-10-30
NCT07022483
A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting
Trial Treatment · Phase 3 · Daiichi Sankyo
Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · Taipei Veterans General Hospital, Taipei · National Taiwan University Hospital, Taipei
Registry updated 2026-10-27
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City · Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · Taipei Veterans General Hospital, Taipei · National Taiwan University Hospital, Taipei · Koo Foundation Sun Yat-Sen Cancer Center, Taipei · MacKay Memorial Hospital, Taipei · Chang Gung Memorial Hospital, Taoyuan
Registry updated 2026-10-26
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
China Medical University Hospital, Taichung · National Cheng Kung University Hospitalx, Tainan · Taipei Veterans General Hospital, Taipei · National Taiwan University Hospital, Taipei · Tri-Service General Hospital, Taipei · Koo Foundation Sun Yat-Sen Cancer Center, Taipei
Registry updated 2026-10-26
NCT06340568
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Trial Treatment · Phase 3 · BioNTech SE
China Medical University Hospital, Taichung · Kuang Tien General Hospital, Taichung · Taichung Veterans General Hospital, Taichung · National Cheng Kung University Hospital, Tainan · Taipei Veterans General Hospital, Taipei · Mackay Memorial Hospital-Taipei branch, Taipei
Registry updated 2026-10-16
NCT05123482
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Trial Treatment · Phase 1/2 · AstraZeneca
Taichung · Tainan · Taipei · Taoyuan
Registry updated 2026-10-13
NCT06952504
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Taichung Veterans General Hospital (Site 3703), Taichung · National Cheng Kung University Hospital (Site 3702), Tainan · Mackay Memorial Hospital (Site 3704), Taipei · National Taiwan University Hospital (Site 3701), Taipei · Linkou Chang Gung Memorial Hospital (Site 3705), Taoyuan
Registry updated 2026-10-13
NCT06989112
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Trial Treatment · Phase 3 · AstraZeneca
Changhua · Kaohsiung City · New Taipei City · Taichung · Tainan · Taipei
Registry updated 2026-10-13
NCT05797168
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Trial Treatment · Phase 1/2 · AstraZeneca
Taichung · Tainan · Taipei
Registry updated 2026-10-05
NCT05489211
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Trial Treatment · Phase 2 · AstraZeneca
Liou Ying Township · Taipei · Taoyuan
Registry updated 2026-09-23
NCT05150691
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Trial Treatment · Phase 1/2 · DualityBio Inc.
Changhua Christian Hospital, Changhua · Kaohsiung Veterans General Hospital, Kaohsiung City · Taipei Medical University Hospital, Taipei · Taipei Medical University-Shuang Ho Hospital, Taipei · Taipei Veterans General Hospital, Taipei · National Taiwan University Hospital, Taipei · Mackay Memorial Hospital-Taipei, Taipei
Registry updated 2026-08-27
NCT07044336
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Trial Treatment · Phase 3 · AstraZeneca
New Taipei City · Taichung · Tainan · Taipei
Registry updated 2026-07-29
NCT07362147
Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life
Trial Treatment · Taipei Veterans General Hospital, Taiwan
Taipei Veterans General Hospital, Taipei
Registry updated 2026-01-23
NCT07114653
The Role of POLE Mutation in High Risk Endometrial Cancer.
Research · Far Eastern Memorial Hospital
Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, Banqiao District
Registry updated 2025-08-11
NCT05034991
The Role of Endometrial Blood Flow in Endometrial Cancer
Research · Far Eastern Memorial Hospital
Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, Banqiao District
Registry updated 2023-03-29

All Endometrial cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error